NEW BRIEF: Focus Groups Overwhelmingly Disapprove of Government “Negotiated” Drug Pricing
PRI | Sally C. Pipes
October 19, 2021
Today, the Pacific Research Institute published an issue brief revealing overwhelming public disapproval for Medicare reforms that Congress is considering as part of its $3.5 trillion spending bill. “It’s a relief that Americans oppose Congress’s drug pricing proposals once voters learn the true consequences of these misguided reforms,” said Sally C. Pipes, the brief’s co-author and PRI president, CEO, and Thomas W. Smith Fellow in Health Care Policy.
Read the study here. . . |
|
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Newsmax | Sally C. Pipes
October 14, 2021
Progressives also want to bring about 23 million additional Americans into Medicare by lowering the program’s eligibility age to 60. They’re looking to add dental, vision, and hearing benefits to the program, too.
Read more. . .
|
|
To Prevent a ‘Twindemic’, Flu Vaccination Is More Important than Ever This Year
American Council on Science and Health | Henry Miller, M.S., M.D.
October 15, 2021
An unprecedented surge of RSV that began during the summer shows what can happen in the absence of the COVID-19 precautions, according to Dr. Gregory Poland, a vaccinologist at Mayo Clinic in Rochester. He warned last month: “I’m not going to talk about a twindemic. I’m going to talk about a tridemic or a quaddemic. We’ve already seen evidence of it. We already have cases of influenza in Minnesota. We’ve already seen evidence of an RSV epidemic.”
|
|
Democrats’ Medicare expansion trick won’t be a treat
The Washington Examiner | Sally C. Pipes
October 19, 2021
Rep. Lloyd Doggett, a Texas Democrat, has expressed concerns that his party’s plan will give low-income seniors “false hope.” And in a letter to committee leaders last week, Rep. Jared Golden, a Maine Democrat, called the plan an “empty promise.” He lamented that wealthy Medicare enrollees would benefit more from the expansion than low-income seniors.
Read more. . .
|
|
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
Forbes | Sally C. Pipes
October 19, 2021
Under the House proposal, the price that Medicare pays for the most popular brand-name drugs would be capped at 120% of the average price paid in six foreign countries: Australia, Canada, France, Germany, Japan, and the United Kingdom. Companies that refuse to sell their medicines at this artificially low price would be subject to an excise tax of as much as 95% on each drug’s gross sales.
Read more. . .
|
|
|
|
